Global Continuous Glucose Monitoring Systems Market to Reach $5.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Continuous Glucose Monitoring Systems estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$5.6 Billion by 2027, growing at a CAGR of 17.6% over the analysis period 2020-2027. Sensors, one of the segments analyzed in the report, is projected to record a 16.4% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transmitters & Receivers segment is readjusted to a revised 18.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $486.2 Million, While China is Forecast to Grow at 22% CAGR
The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$486.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 22% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 16.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.1% CAGR.
Integrated Insulin Pumps Segment to Record 21.3% CAGR
In the global Integrated Insulin Pumps segment, USA, Canada, Japan, China and Europe will drive the 20.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$193.9 Million in the year 2020 will reach a projected size of US$714.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$811.5 Million by the year 2027, while Latin America will expand at a 22.6% CAGR through the analysis period.
Select Competitors (Total 53 Featured):
Amid the COVID-19 crisis, the global market for Continuous Glucose Monitoring Systems estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$5.6 Billion by 2027, growing at a CAGR of 17.6% over the analysis period 2020-2027. Sensors, one of the segments analyzed in the report, is projected to record a 16.4% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transmitters & Receivers segment is readjusted to a revised 18.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $486.2 Million, While China is Forecast to Grow at 22% CAGR
The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$486.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 22% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 16.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.1% CAGR.
Integrated Insulin Pumps Segment to Record 21.3% CAGR
In the global Integrated Insulin Pumps segment, USA, Canada, Japan, China and Europe will drive the 20.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$193.9 Million in the year 2020 will reach a projected size of US$714.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$811.5 Million by the year 2027, while Latin America will expand at a 22.6% CAGR through the analysis period.
Select Competitors (Total 53 Featured):
- A. Menarini Diagnostics
- Abbott Laboratories
- Animas Corporation
- Baxter International Inc
- Dexcom, Inc.
- Echo Therapeutics, Inc.
- F. Hoffmann-La Roche Ltd.
- GlySens Incorporated
- Johnson & Johnson
- Medtronic plc
- Novo Nordisk
- Pfizer Inc.
- Senseonics Holdings, Inc.
- Ypsomed
Frequently Asked Questions about the Global Market for Continuous Glucose Monitoring Systems
What is the estimated value of the Global Market for Continuous Glucose Monitoring Systems?
What is the growth rate of the Global Market for Continuous Glucose Monitoring Systems?
What is the forecasted size of the Global Market for Continuous Glucose Monitoring Systems?
Note: Product cover images may vary from those shown
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
1. MARKET OVERVIEW
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
